Better Therapeutics, Inc. (BTTX)
OTCMKTS: BTTX · Delayed Price · USD
0.0131
+0.0002 (1.55%)
Mar 28, 2024, 10:01 AM EDT - Market open

Better Therapeutics Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Year 2022202120202019
Cash & Equivalents
15.7440.570.120.76
Cash & Cash Equivalents
15.7440.570.120.76
Cash Growth
-61.20%32880.49%-83.75%-
Other Current Assets
2.714.690.340.23
Total Current Assets
18.4545.250.460.99
Property, Plant & Equipment
0.120.080.090.18
Intangible Assets
3.895.085.563.27
Other Long-Term Assets
0.490.550.280.44
Total Long-Term Assets
4.55.715.923.89
Total Assets
22.9450.966.394.88
Accounts Payable
3.041.520.510.34
Current Debt
4.53000
Other Current Liabilities
5.933.210.10.15
Total Current Liabilities
13.494.730.610.49
Long-Term Debt
10.359.510.645
Other Long-Term Liabilities
0011.890
Total Long-Term Liabilities
10.359.5112.535
Total Liabilities
23.8414.2413.155.49
Total Debt
14.889.510.645
Debt Growth
56.55%1385.16%-87.20%-
Common Stock
0000.21
Retained Earnings
-111.5-71.74-31.41-25.02
Shareholders' Equity
-0.936.72-6.76-0.61
Total Liabilities and Equity
22.9450.966.394.88
Net Cash / Debt
0.8631.06-0.52-4.24
Net Cash / Debt Growth
-97.23%---
Net Cash Per Share
0.042.39-0.02-0.18
Working Capital
4.9540.52-0.150.5
Book Value Per Share
-0.042.83-0.29-0.03
Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.